Connect with us

Hi, what are you looking for?

Jewish Business News

VC, Investments

Israeli DataOps Startup K2View Raises $28 Million

According to K2Vie, its platform provides the right data to the right person at the right time in just milliseconds.

Israeli real-time DataOps solutions company K2View today announced the completion of a $28 million financing round led by Forestay Capital, with the participation of Genesis Partners.

Founded in 2009 by CEO Achi Rotem and COO Rafi Cohen, K2View developed patented technology to deliver vital data that enterprises need, exactly how and when they need it – all in real-time.

The company says its platform provides the right data to the right person at the right time in just milliseconds and enables enterprises to operationalize all of their data and get holistic access to what matters the most to their business, while reducing time-to-market from months to weeks.

The company has offices in Israel in three locations and in the US.

K2View helping some of the world’s largest companies tackle complex data challenges. The funds will speed up the company’s growth in fields such as insurance, telecom, financial services, logistics, healthcare, and more.

CEO Achi Rotem said, “The fastest method to achieve true agility and exceptional customer experience is moving away from 30-plus years of application-driven enterprise into the data-driven enterprise. This is a critical component for digital transformation and a massive opportunity for us. As we look to the next stage of our growth, our vision is to continue helping companies unlock their potential by providing a faster, better and more cost-effective way to access and control data.”

 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Advertisement